Insider · CIK 0001705673
Suzanne Patricia Clark
Files at AGCO (AGCO CORP /DE), TRU (TransUnion). First filing -, latest -.
In brief
Suzanne Patricia Clark files SEC Form 4 as director at AGCO (AGCO CORP /DE), and also at TRU (TransUnion). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Suzanne Patricia Clark has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | TRU TransUnion | AGrant or award Common Stock | +3,034 | $0.00 | $0 | 25,588 | May 13, 2026 |
| Apr 23, 2026 | AGCO AGCO CORP /DE | AGrant or award Common Stock | +1,673 | $0.00 | $0 | 14,314 | Apr 27, 2026 |
| May 7, 2025 | TRU TransUnion | AGrant or award Common Stock | +2,463 | $0.00 | $0 | 22,554 | May 9, 2025 |
| Apr 24, 2025 | AGCO AGCO CORP /DE | AGrant or award Common Stock | +2,157 | $0.00 | $0 | 12,641 | Apr 28, 2025 |
Questions about Suzanne Patricia Clark
Answered from the filings on this page, as of the latest one.
Is Suzanne Patricia Clark buying or selling?
Suzanne Patricia Clark has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Suzanne Patricia Clark's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Suzanne Patricia Clark has 0.
Where does Suzanne Patricia Clark file Form 4?
Suzanne Patricia Clark has filed Form 4 at AGCO (AGCO CORP /DE); TRU (TransUnion). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.